BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 17507008)

  • 21. Techniques for studying inverse agonist activity of antidepressants at recombinant nonedited 5-HT(₂C-INI) receptor and native neuronal 5-HT(₂C) receptors.
    Seimandi M; Bockaert J; Marin P
    Methods Enzymol; 2010; 485():61-79. PubMed ID: 21050911
    [TBL] [Abstract][Full Text] [Related]  

  • 22. RNA splicing and editing modulation of 5-HT(2C) receptor function: relevance to anxiety and aggression in VGV mice.
    Martin CB; Ramond F; Farrington DT; Aguiar AS; Chevarin C; Berthiau AS; Caussanel S; Lanfumey L; Herrick-Davis K; Hamon M; Madjar JJ; Mongeau R
    Mol Psychiatry; 2013 Jun; 18(6):656-65. PubMed ID: 23247076
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oligomer size of the serotonin 5-hydroxytryptamine 2C (5-HT2C) receptor revealed by fluorescence correlation spectroscopy with photon counting histogram analysis: evidence for homodimers without monomers or tetramers.
    Herrick-Davis K; Grinde E; Lindsley T; Cowan A; Mazurkiewicz JE
    J Biol Chem; 2012 Jul; 287(28):23604-14. PubMed ID: 22593582
    [TBL] [Abstract][Full Text] [Related]  

  • 24. RNA editing of the serotonin 2C receptor and expression of Galpha(q) protein: genetic mouse models do not support a role for regulation or compensation.
    Canal CE; Mahautmr KC; Cao C; Sanders-Bush E; Airey DC
    J Neurochem; 2009 Mar; 108(5):1136-42. PubMed ID: 19154337
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacological properties of the Cys23Ser single nucleotide polymorphism in human 5-HT2C receptor isoforms.
    Fentress HM; Grinde E; Mazurkiewicz JE; Backstrom JR; Herrick-Davis K; Sanders-Bush E
    Pharmacogenomics J; 2005; 5(4):244-54. PubMed ID: 15912142
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hippocampal serotonin depletion facilitates the enhancement of prepulse inhibition by risperidone: possible role of 5-HT(2C) receptors in the dorsal hippocampus.
    Adams W; van den Buuse M
    Neuropharmacology; 2011 Sep; 61(3):458-67. PubMed ID: 21477601
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Constitutive and agonist-dependent homo-oligomerization of the thyrotropin-releasing hormone receptor. Detection in living cells using bioluminescence resonance energy transfer.
    Kroeger KM; Hanyaloglu AC; Seeber RM; Miles LE; Eidne KA
    J Biol Chem; 2001 Apr; 276(16):12736-43. PubMed ID: 11278883
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterisation of agonist binding on human 5-HT2C receptor isoforms.
    Quirk K; Lawrence A; Jones J; Misra A; Harvey V; Lamb H; Revell D; Porter RH; Knight AR
    Eur J Pharmacol; 2001 May; 419(2-3):107-12. PubMed ID: 11426831
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Establishment and characterization of RNA-edited serotonin 2C receptor isoform cell models and alteration of amyloid precursor protein ectodomain secretion in HEK293 APPSwe cells.
    Guo L; Zhang J; Yan Q; Yin M
    Hum Cell; 2011 Jun; 24(2):104-11. PubMed ID: 21584765
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dynamic modulation of FGFR1-5-HT1A heteroreceptor complexes. Agonist treatment enhances participation of FGFR1 and 5-HT1A homodimers and recruitment of β-arrestin2.
    Borroto-Escuela DO; Corrales F; Narvaez M; Oflijan J; Agnati LF; Palkovits M; Fuxe K
    Biochem Biophys Res Commun; 2013 Nov; 441(2):387-92. PubMed ID: 24157794
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Real-time analysis of agonist-induced activation of protease-activated receptor 1/Galphai1 protein complex measured by bioluminescence resonance energy transfer in living cells.
    Ayoub MA; Maurel D; Binet V; Fink M; Prézeau L; Ansanay H; Pin JP
    Mol Pharmacol; 2007 May; 71(5):1329-40. PubMed ID: 17267663
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serotonin 5-HT2C receptor homodimer biogenesis in the endoplasmic reticulum: real-time visualization with confocal fluorescence resonance energy transfer.
    Herrick-Davis K; Weaver BA; Grinde E; Mazurkiewicz JE
    J Biol Chem; 2006 Sep; 281(37):27109-16. PubMed ID: 16857671
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Current status of inverse agonism at serotonin2A (5-HT2A) and 5-HT2C receptors.
    Aloyo VJ; Berg KA; Spampinato U; Clarke WP; Harvey JA
    Pharmacol Ther; 2009 Feb; 121(2):160-73. PubMed ID: 19109993
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Physiological and therapeutic relevance of constitutive activity of 5-HT 2A and 5-HT 2C receptors for the treatment of depression.
    Berg KA; Harvey JA; Spampinato U; Clarke WP
    Prog Brain Res; 2008; 172():287-305. PubMed ID: 18772038
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of beta 2-adrenergic receptor dimerization in living cells using bioluminescence resonance energy transfer (BRET).
    Angers S; Salahpour A; Joly E; Hilairet S; Chelsky D; Dennis M; Bouvier M
    Proc Natl Acad Sci U S A; 2000 Mar; 97(7):3684-9. PubMed ID: 10725388
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insights into the influence of 5-HT2c aminoacidic variants with the inhibitory action of serotonin inverse agonists and antagonists.
    Galeazzi R; Massaccesi L; Piva F; Principato G; Laudadio E
    J Mol Model; 2014 Mar; 20(3):2120. PubMed ID: 24562856
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacology of 5HT(2C) receptor-mediated ERK1/2 phosphorylation: agonist-specific activation pathways and the impact of RNA editing.
    Werry TD; Stewart GD; Crouch MF; Watts A; Sexton PM; Christopoulos A
    Biochem Pharmacol; 2008 Nov; 76(10):1276-87. PubMed ID: 18812172
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Physical interaction of calmodulin with the 5-hydroxytryptamine2C receptor C-terminus is essential for G protein-independent, arrestin-dependent receptor signaling.
    Labasque M; Reiter E; Becamel C; Bockaert J; Marin P
    Mol Biol Cell; 2008 Nov; 19(11):4640-50. PubMed ID: 18768750
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inverse agonist actions of typical and atypical antipsychotic drugs at the human 5-hydroxytryptamine(2C) receptor.
    Rauser L; Savage JE; Meltzer HY; Roth BL
    J Pharmacol Exp Ther; 2001 Oct; 299(1):83-9. PubMed ID: 11561066
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Agonist-induced functional desensitization of recombinant human 5-HT2 receptors expressed in CHO-K1 cells.
    Porter RH; Malcolm CS; Allen NH; Lamb H; Revell DF; Sheardown MJ
    Biochem Pharmacol; 2001 Aug; 62(4):431-8. PubMed ID: 11448452
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.